@topoke_girl: A World Health Organization advisory group has backed further research in the Democratic Republic of the Congo to assess whether the Ervebo vaccine, developed for the Zaire strain of Ebola, could provide protection against the rare Bundibugyo virus. WHO says current evidence is insufficient to determine whether Ervebo is effective against the strain. Epidemiologist Placide Mbala of the University of Kinshasa discusses the proposed research and its potential implications for the outbreak response. #GENOCOST #education #rdcongo🇨🇩 #freecongo🇨🇩 #burunditiktok🇧🇮